Published in TB and Outbreaks Week, April 16th, 2002
The discovery of how the immune-suppressing drugs enhance the action of antifungal drugs could lead to the development of new drugs designed to treat fungal infections such as systemic yeast infections and often-deadly cryptococcal infections.
Led by Dr. Joseph Heitman, who is a Howard Hughes Medical Institute investigator at Duke, the research team...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week